Lithiumchlorid: ein wirksamer Wirkstoff gegen Varroa?
Das Institut für Bienenkunde der Universität Hohenheim hat eine wirksame Substanz gegen die Varroamilbe entdeckt: Lithiumchlorid.
Dies ist eine sehr gute Nachricht, auch wenn der Wirkstoff – bevor er als Arzneimittel für Bienen auf den Markt gebracht werden kann – selbstverständlich noch weiter getestet werden muss, um die optimale Dosierung festzulegen und Nebenwirkungen für die Bienen und die Anwender sowie das Risiko von Rückständen auszuschließen. Es wird daher noch einige Zeit dauern, bis die Varroabekämpfung optimiert werden kann.
German researchers have recently published a study on the effectiveness of lithium in the treatment of Varroa destructor. The incorporation of lithium into the feeding syrup appears to affect varroa mites through an acaricidal mechanism that is still not fully understood. The bees themselves do not seem to exhibit noticeable side effects, and their survival does not appear to be impaired.
Lithium, well known in human pharmacology, therefore represents a potentially promising approach, although further studies in apiculture are clearly required.
For more details, see the press release from the University of Hohenheim (in German) or the corresponding scientific article published in Scientific Reports (in English).
Lithium chloride against varroa – a promising approach with open questions
This article discusses the discovery of the acaricidal effect of lithium chloride against Varroa destructor and places its significance in the context of beekeeping practice. The discussion is based on a study conducted at the University of Hohenheim and published in the journal Scientific Reports, which demonstrated for the first time that lithium salts are highly toxic to varroa mites.
Laboratory experiments using varroa-infested worker bees in test cages showed very high efficacy of lithium chloride combined with good tolerance in adult bees. Additional trials on nine artificial swarms treated via sugar syrup achieved an efficacy close to 90%, comparable to results obtained with established oxalic acid treatments. A potential advantage of lithium chloride is that its effectiveness does not depend on temperature or humidity, unlike formic acid or essential oils, which could allow for more stable application and reduce the risk of queen losses.
However, the authors clearly emphasize that these findings represent only a starting point. A key issue remains the demonstration of efficacy in full production colonies containing brood. Since varroa mites reproduce within sealed brood cells, an effective treatment would need to act for at least two weeks. At the same time, it must be ensured that prolonged exposure does not negatively affect brood or adult bees.
Another central concern relates to residues and environmental aspects. Lithium chloride is water-soluble, making accumulation in wax unlikely. It remains unclear, however, whether residues could occur in honey and what implications this might have for human health. Although lithium salts have been used in medicine since the 19th century, they are not biodegradable and could potentially accumulate in the environment.
Regarding potential commercialization, the authors caution against unrealistic expectations. They consider it likely that several years will be required before a lithium-based veterinary medicinal product could be authorized. They explicitly warn against any improvised or uncontrolled use of lithium by beekeepers.
Finally, the article places lithium chloride research within the broader context of varroa control. While lithium opens up interesting new perspectives, breeding for varroa-resistant bees remains a long-term objective. Until then, beekeepers must continue to rely on proven and recommended control strategies.
Conclusion: Lithium chloride represents a scientifically very promising avenue in varroa control, but it is still far from being a practical, field-ready solution. Patience, rigorous research and thorough regulatory assessment are essential.